CV:TBP Tetra Bio-Pharma Inc.

Tetra Bio-Pharma, Inc. engages in the discovery and development of cannabinoid-based drugs and treatments. The company focuses on the ophthalmic, chronic pain, and oncology drug formulations. It also plans to commercialize terpene based products aimed towards the over-the-counter (OTC) and behind the counter (BTC) market. The company was founded by Ryan Brown and Andre D. Audet on May 17, 2007 and is headquartered in Longueuil, Canada.

This company cross-lists their shares on a U.S. stock exchange. See the related U.S. symbol TBPMF.

0.22 CAD
As of 07/31/2020


Security Information
Category1:  Global Equity
Category2:  Common stocks
Category3:  Developed markets ex-US
GICS sector:  Communication Services
Industry:  Biotechnology
Index country:  Canada
Country of incorporation:  
IPO date:  01/01/1900
Stock exchange:    TSX Venture Exchange
Exchange country:   Canada
Market cap:   0 CAD
Current dividend yield:   0.00%
CUSIP:    
ISIN:        
Sedol:      BDCBXM4

2021 © Stock Market MBA, Inc. Terms of use | Privacy policy